These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The lncRNA VPS9D1-AS1 Promotes Hepatocellular Carcinoma Cell Cycle Progression by Regulating the HuR/CDK4 Axis. Zhou N, Li S, Wu D, Zhang F, Tang F, Li Y. DNA Cell Biol; 2021 Oct 04; 40(10):1278-1289. PubMed ID: 34558987 [Abstract] [Full Text] [Related]
8. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, Yan M, Ge C, Zhang Z, Chen T, Wan D, Yao M, Li J, Gu J, He X. Hepatology; 2010 Mar 04; 51(3):846-56. PubMed ID: 20054866 [Abstract] [Full Text] [Related]
11. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Sun X, Shi C, Dai J, Zhang MQ, Pei DS, Yang L. Cell Death Dis; 2024 May 20; 15(5):346. PubMed ID: 38769124 [Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis. Zhang Z, Zhao Q, Wang Z, Xu F, Liu Y, Guo Y, Li C, Liu T, Zhao Y, Tang X, Zhang J. Hepatol Commun; 2024 Mar 01; 8(3):. PubMed ID: 38437062 [Abstract] [Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Frau M, Feo F, Pascale RM. J Hepatol; 2013 Oct 01; 59(4):830-41. PubMed ID: 23665184 [Abstract] [Full Text] [Related]